The legalization of medical cannabis is becoming increasingly important in a country grappling with post-trauma. Sharon LuxenburgMapat, a research directorate for defense technology, is at the forefront of utilizing scientific and technological advancements to help IDF soldiers suffering from post-trauma, depression, and anxiety. Dr. Avi Shoshani, a brain researcher based in Jerusalem, has developed a new device in collaboration with psychiatrists to address the shortcomings of current treatments for mental health issues faced by returning warriors.
The device uses sensorimotor contacts to teach the brain a special language that enhances its sensitivity to changes in the body following traumatic experiences. Unlike traditional treatments that can be burdensome and have severe side effects, the brainpower device offers a more gentle and effective approach. It stimulates specific brain centers related to depression and anxiety through variable stimuli speeds and densities, similar to mindfulness techniques but with greater precision.
With a significant portion of the population in Israel relying on antidepressants and anxiety medications, the need for innovative treatments like the brainpower device is evident. Following conflicts like the war in Gaza, the number of individuals diagnosed with mental health issues has risen sharply. The new technology shows potential for improving the quality of life for those struggling with post-trauma and mental health disorders.
In conclusion, while medical cannabis legalization may be important for some patients seeking relief from trauma-related conditions, there are also other innovative solutions available that can provide effective treatment without burdening patients or causing severe side effects. The brainpower device developed by Dr. Shoshani is just one such solution that could make a significant impact on improving mental health outcomes for those in need.